Tag: minimally invasive glaucoma surgery migs devices market size

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

The minimally invasive glaucoma surgery (migs) devices market size has experienced substantial growth in recent years. It is projected to expand from $0.89 billion in 2025 to $1.14 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 28.1%. Factors contributing to this historical growth include the rising prevalence of glaucoma, an expanding aging demographic, the inherent limitations of traditional glaucoma surgeries, increasing awareness regarding vision preservation, and the growing adoption of cataract procedures.

The minimally invasive glaucoma surgery (migs) devices market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.9%. This expansion during the forecast period can be primarily attributed to an increasing number of glaucoma patients, greater acceptance of less invasive surgical choices, a rising need for outpatient eye procedures, a heightened emphasis on improved quality-of-life results, and broadened availability of specialized eye care clinics. Key developments during this period include a surge in the adoption of minimally invasive glaucoma interventions, a growing inclination towards MIGS for early and moderate stages of glaucoma, increased application of MIGS alongside cataract operations, the proliferation of outpatient and ambulatory glaucoma surgeries, and a heightened desire for glaucoma treatments that are both safer and facilitate quicker recovery.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=82885192&type=smp&name=Minimally%20Invasive%20Glaucoma%20Surgery%20%28MIGS%29%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth Backed By Core Demand Fundamentals

The future expansion of the minimally invasive glaucoma surgery (MIGS) devices market is anticipated due to the rising occurrence of eye disorders. These disorders encompass diverse conditions impacting sight and the eyes, with their increasing prevalence attributed to shifts in lifestyle, environmental factors, and an aging global demographic. Minimally invasive glaucoma surgery (MIGS) devices represent advanced instruments employed in treating various ocular ailments, principally aimed at lowering intraocular pressure (IOP) to halt or manage glaucoma’s progression. A notable example cited in 2024 by the National Eye Institute, a US-based government agency, indicates that around 2.2 million Americans will be blind or partially blind by 2030. Consequently, the growing frequency of eye disorders is a key force behind the minimally invasive glaucoma surgery (MIGS) devices market.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segment Landscape: Which Areas Lead Development?

The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –

1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices

2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures

3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space

4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals

Subsegments:

1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents

2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts

3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents

4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth Trends Reshaping The Competitive Landscape

Leading companies within the minimally invasive glaucoma surgery (MIGS) devices market are prioritizing the development of sophisticated solutions, such as sustained-release drug-delivery implants, designed to supersede conventional topical glaucoma therapies. A sustained-release implant functions as a device that continually administers medication over time, consequently boosting patient adherence, decreasing the frequency of dosing, and elevating treatment effectiveness. For example, in February 2024, Celanese Corporation, a US-based specialty materials company, formed a partnership with Glaukos to commercially introduce the iDose® TR (Travoprost Intracameral Implant), leveraging Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This innovative product substitutes traditional eye-drop regimens by providing ongoing intraocular delivery of travoprost directly into the eye for several months. Integrated within Glaukos’ MIGS portfolio, it furnishes a minimally invasive therapeutic alternative that diminishes the requirement for daily eye drops, improves patient compliance, and supports consistent intraocular pressure regulation, ultimately improving long-term treatment outcomes.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver‑Visitec International

View The Full Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:

https://thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Regional Outlook: Where Is Opportunity Concentrated?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The minimally invasive glaucoma surgery (MIGS) devices market is undergoing rapid expansion, driven by advancements in surgical techniques and growing awareness of eye health. As glaucoma continues to affect millions worldwide, the demand for less invasive and more effective treatment options has never been higher. Let’s explore the market’s current size, key growth drivers, leading players, and emerging trends shaping the future of MIGS devices.

Strong Growth Trajectory in the Minimally Invasive Glaucoma Surgery Devices Market

The MIGS devices market has seen remarkable growth in recent years. It is projected to rise from $0.89 billion in 2025 to $1.14 billion in 2026, representing a compound annual growth rate (CAGR) of 28.1%. Several factors contributed to this growth, including the rising prevalence of glaucoma, an aging global population, the limitations of traditional glaucoma surgeries, greater awareness about vision preservation, and increasing rates of cataract surgeries. Looking ahead, the market is expected to expand even further, reaching $2.79 billion by 2030 with a CAGR of 24.9%. This forecasted growth is supported by an expanding pool of glaucoma patients, wider acceptance of minimally invasive procedures, increasing demand for outpatient eye surgeries, a stronger focus on patients’ quality of life, and the growing availability of specialized eye care clinics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Key Factors Supporting Growth in the MIGS Devices Market

The rising incidence of eye disorders plays a significant role in driving the demand for MIGS devices. Eye conditions, including glaucoma, are becoming more common due to lifestyle changes, environmental factors, and an aging population worldwide. MIGS devices are designed to manage these diseases by effectively lowering intraocular pressure (IOP), which is critical in preventing the progression of glaucoma. For instance, according to the National Eye Institute, approximately 2.2 million Americans will be blind or partially blind by 2030, underscoring the urgent need for improved treatment options like MIGS.

Expanding Patient Acceptance and Technology Adoption in MIGS

Another key driver is the growing acceptance of minimally invasive surgical options among patients and healthcare providers. These procedures offer benefits such as quicker recovery times, reduced complications, and suitability for outpatient settings. Additionally, combining MIGS with cataract surgery has become increasingly popular, allowing for dual treatment in one surgical session. This integration supports the market’s expansion by appealing to a broader patient base seeking safer and more efficient eye care.

Access The Complete Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

How the MIGS Devices Market Is Categorized for In-Depth Analysis

This market is segmented into several categories to better understand its dynamics:

1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, and Canaloplasty & Schlemm’s Canal Devices

2) By Surgical Approach: MIGS performed alongside cataract surgery, and Stand-Alone MIGS procedures

3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, and Subconjunctival Space

4) By Procedure Type: Ab-Interno MIGS and Ab-Externo MIGS

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), and Specialized Eye Hospitals

The report further breaks down subsegments such as single-lumen and multi-lumen trabecular micro-stents, various types of subconjunctival micro-shunts, passive and flow-regulated suprachoroidal stents, and different canaloplasty devices including implant-free systems.

Innovations Transforming the Minimally Invasive Glaucoma Surgery Devices Market

Leading companies in the MIGS space are focusing on breakthroughs like sustained-release drug-delivery implants to replace conventional eye-drop treatments. These implants provide continuous medication delivery, improving patient adherence and treatment effectiveness by reducing the need for frequent dosing. A notable example is the February 2024 launch by Celanese Corporation in partnership with Glaukos of the iDose® TR Implant, which uses Celanese’s VitalDose® Ethylene Vinyl Acetate platform. This device delivers travoprost directly inside the eye over several months, offering a minimally invasive alternative to daily eye drops and enhancing long-term control of intraocular pressure.

Competitive Landscape of the MIGS Devices Industry

The minimally invasive glaucoma surgery devices market is populated by several prominent companies, including Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., and Beaver-Visitec International. These players compete through continuous innovation and strategic partnerships to maintain market leadership.

Geographic Highlights Demonstrate Market Leaders and Emerging Regions

In 2025, North America held the largest share of the MIGS devices market, benefiting from high healthcare expenditure and advanced ophthalmic infrastructure. However, the Asia-Pacific region is anticipated to exhibit the fastest growth during the forecast period, driven by increasing healthcare investments, rising awareness of glaucoma treatment options, and expanding access to specialized eye care across countries such as China, India, and Japan. Other important markets include South East Asia, Western and Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive global perspective on the market’s development.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Between 2026 And 2030?

The minimally invasive glaucoma surgery (migs) devices market size has experienced considerable expansion in recent years. It is anticipated to grow from $0.89 billion in 2025 to $1.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.1%. The growth observed in prior periods can be attributed to the increasing prevalence of glaucoma, a growing aging population, the limitations inherent in conventional glaucoma surgeries, heightened awareness of vision preservation, and the increasing adoption of cataract surgeries.

The market for minimally invasive glaucoma surgery (migs) devices is projected to experience rapid expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $2.79 billion, demonstrating a compound annual growth rate (CAGR) of 24.9%. Factors contributing to this growth during the projection period include an increasing number of glaucoma patients, a greater embrace of minimally invasive surgical alternatives, a surge in the need for outpatient eye surgeries, an enhanced emphasis on patient quality-of-life results, and improved availability of dedicated ophthalmology centers. Key trends expected within the forecast timeframe encompass the increasing implementation of minimally invasive glaucoma interventions, a developing preference for MIGS in the initial and moderate stages of glaucoma, an escalated application of MIGS alongside cataract operations, the broadening scope of outpatient and ambulatory glaucoma interventions, and a heightened requirement for glaucoma treatments offering greater safety and quicker recuperation.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Which Strategic Drivers Are Supporting The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Development?

The growing occurrence of eye conditions is anticipated to propel the expansion of minimally invasive glaucoma surgery (MIGS) devices in the future. These disorders encompass a broad spectrum of conditions affecting vision and the eyes. The increasing prevalence of eye disorders is linked to shifts in lifestyle, environmental influences, and an aging global demographic. Minimally invasive glaucoma surgery (MIGS) devices are innovative tools used in managing various ocular diseases, primarily aiming to lower intraocular pressure (IOP) to prevent or control the progression of glaucoma. For instance, in 2024, according to the National Eye Institute, a US-based government agency, around 2.2 million Americans will be blind or partially blind by 2030. Therefore, the rising prevalence of eye disorders is a key driver for the minimally invasive glaucoma surgery (MIGS) devices market.

Which Segment Divisions Form The Structure Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –

1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices

2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures

3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space

4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals

Subsegments:

1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents

2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts

3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents

4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices

What Trends Are Driving Changes In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Leading companies within the minimally invasive glaucoma surgery (MIGS) devices market are concentrating their efforts on creating sophisticated solutions, like sustained-release drug-delivery implants, as alternatives to conventional topical glaucoma treatments. Such sustained-release implants function by continuously administering medication over an extended period, which consequently boosts patient adherence, minimizes the frequency of dosage, and amplifies the overall effectiveness of the treatment. An example of this trend occurred in February 2024 when Celanese Corporation, a US-based specialty materials company, collaborated with Glaukos to commercially introduce the iDose® TR (Travoprost Intracameral Implant). This product leverages Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This particular innovation offers a continuous intraocular delivery of travoprost directly into the eye for several months, effectively replacing the need for traditional eye-drop regimens. When integrated with Glaukos’ MIGS portfolio, it provides a minimally invasive therapeutic choice that diminishes the requirement for daily eye drops, fosters better patient compliance, and helps maintain consistent intraocular pressure, leading to improved long-term treatment outcomes.

Which Companies Are Engaged In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Environment?

Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International

Access The Complete Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Contributes The Most To The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company

Glaucoma Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Cataract Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cataract-surgery-devices-and-equipment-global-market-report

Ophthalmic Handheld Surgical Instruments Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-handheld-surgical-instruments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Progress Between 2026 And 2030?

The minimally invasive glaucoma surgery (migs) devices market size has experienced significant expansion in recent years. Projections indicate it will grow from $0.89 billion in 2025 to $1.14 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 28.1%. This historical development is attributable to factors such as the increasing prevalence of glaucoma, a growing aging population, the limitations of conventional glaucoma surgeries, heightened awareness of vision preservation, and the increasing adoption of cataract surgeries.

The minimally invasive glaucoma surgery (migs) devices market size is projected to experience significant expansion in the coming years. It is anticipated to reach $2.79 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 24.9%. This growth throughout the forecast period can be primarily attributed to an expanding population of glaucoma patients, increasing acceptance of minimally invasive surgical options, a rising demand for outpatient ophthalmic procedures, a greater focus on quality-of-life outcomes, and improved access to specialized ophthalmology clinics. Furthermore, major trends in the forecast period involve the increasing adoption of minimally invasive glaucoma procedures, a growing preference for MIGS in early and moderate glaucoma, the escalating use of MIGS combined with cataract surgery, an expansion of outpatient and ambulatory glaucoma surgeries, and an increasing demand for safer and quicker-recovery glaucoma treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Factors Are Influencing The Growth Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The escalating incidence of eye disorders is anticipated to fuel the growth of minimally invasive glaucoma surgery (MIGS) devices moving forward. Eye disorders encompass a diverse array of conditions that influence both ocular health and vision. This increase in eye disorder prevalence stems from shifts in lifestyle, environmental influences, and the growing elderly population. Minimally invasive glaucoma surgery (MIGS) devices are innovative instruments employed in addressing various ophthalmic diseases, with a core focus on reducing intraocular pressure (IOP) to prevent or control the advancement of glaucoma. As an illustration, the National Eye Institute, a US government organization, stated in 2024 that around 2.2 million Americans are expected to be blind or partially blind by 2030. Thus, the rising occurrence of eye disorders acts as a key driver for the minimally invasive glaucoma surgery (MIGS) devices market.

How Is The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Categorized Across Its Segment Groups?

The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –

1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices

2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures

3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space

4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals

Subsegments:

1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents

2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts

3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents

4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices

Which Trends Are Influencing Demand In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Leading companies in the minimally invasive glaucoma surgery (MIGS) devices market are prioritizing the development of sophisticated solutions, such as sustained-release drug-delivery implants, to substitute traditional topical glaucoma treatments. A sustained-release implant is defined as a device designed to dispense medication continuously over a period, thereby improving patient commitment to treatment, decreasing dosing frequency, and enhancing overall therapeutic efficacy. An illustrative example occurred in February 2024, when Celanese Corporation, a US-based specialty materials firm, partnered with Glaukos for the commercial introduction of the iDose® TR (Travoprost Intracameral Implant). This product employs Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This breakthrough innovation offers continuous intraocular delivery of travoprost directly into the eye for several months, replacing conventional eye-drop routines. Integrated within Glaukos’ MIGS portfolio, it presents a minimally invasive treatment option that reduces the daily requirement for eye drops, enhances patient adherence, and supports sustained control of intraocular pressure, ultimately leading to improved long-term treatment outcomes.

Which Firms Are Influencing Competition In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International

Get The Full Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Accounts For The Largest Portion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company

Glaucoma Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Cataract Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cataract-surgery-devices-and-equipment-global-market-report

Ophthalmic Handheld Surgical Instruments Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-handheld-surgical-instruments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Over The 2026–2030 Period?

The minimally invasive glaucoma surgery (migs) devices market size has experienced rapid expansion in recent years. It is projected to expand from $0.89 billion in 2025 to $1.14 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 28.1%. This historical growth can be ascribed to factors such as the increasing prevalence of glaucoma, a growing aging population, the limitations inherent in conventional glaucoma surgeries, heightened awareness regarding vision preservation, and the rising adoption of cataract surgeries.

The minimally invasive glaucoma surgery (migs) devices market size is anticipated to experience significant expansion over the coming years, with projections indicating a rise to $2.79 billion by 2030, driven by a compound annual growth rate (CAGR) of 24.9%. This projected growth throughout the forecast period stems from factors such as an enlarging glaucoma patient population, increased embrace of minimally invasive surgical alternatives, a surging demand for outpatient ophthalmic interventions, a heightened focus on patient quality-of-life outcomes, and improved access to specialized ophthalmology clinics. Noteworthy trends expected in this timeframe include the increasing uptake of minimally invasive glaucoma procedures, a growing inclination towards MIGS for early and moderate glaucoma cases, the expanding practice of combining MIGS with cataract surgery, an increase in outpatient and ambulatory glaucoma surgeries, and a sustained demand for glaucoma treatments offering enhanced safety and quicker recovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Which Major Factors Are Driving The Expansion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The rising occurrence of eye conditions is anticipated to drive the expansion of the minimally invasive glaucoma surgery (MIGS) devices market in the future. These conditions refer to numerous ailments impacting ocular health and sight. Their prevalence is on the rise, attributed to evolving lifestyle habits, environmental factors, and an aging demographic. Minimally invasive glaucoma surgery (MIGS) devices represent advanced instruments employed in treating diverse ocular diseases, with a primary goal of lowering intraocular pressure (IOP) to impede or manage glaucoma’s advancement. For illustration, data from 2024, provided by the National Eye Institute, a US-based government agency, indicates that approximately 2.2 million Americans are projected to experience blindness or partial vision loss by 2030. Consequently, the growing incidence of eye disorders significantly propels the minimally invasive glaucoma surgery (MIGS) devices market.

How Is The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmented Across Key Categories?

The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –

1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices

2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures

3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space

4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals

Subsegments:

1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents

2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts

3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents

4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices

Which Upcoming Trends Are Expected To Influence The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Key players within the minimally invasive glaucoma surgery (MIGS) devices market are concentrating their efforts on creating sophisticated solutions, like sustained-release drug-delivery implants, designed to supersede conventional topical glaucoma therapies. Such an implant is defined as a mechanism that administers medication without interruption over an extended period, leading to better patient compliance, fewer required doses, and more effective treatment outcomes. As an example, in February 2024, Celanese Corporation, a US-based specialty materials firm, collaborated with Glaukos for the commercial introduction of the iDose® TR (Travoprost Intracameral Implant), leveraging Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This groundbreaking product supersedes conventional eye-drop routines by ensuring a constant intraocular supply of travoprost straight into the eye for an duration of multiple months. Incorporated into Glaukos’ MIGS product range, it presents a therapeutic choice that is minimally invasive, lessening the necessity for daily eye drops, boosting patient adherence, and facilitating consistent intraocular pressure management, which ultimately betters long-term treatment results.

Who Are The Dominant Players Shaping The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Landscape?

Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International

Read the full minimally invasive glaucoma surgery (migs) devices market report here:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Currently Holds The Largest Share Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company

Glaucoma Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Cataract Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cataract-surgery-devices-and-equipment-global-market-report

Ophthalmic Handheld Surgical Instruments Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-handheld-surgical-instruments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market between 2026 and 2030?

The minimally invasive glaucoma surgery (MIGS) devices market size has seen substantial growth recently. It is forecast to rise from $0.89 billion in 2025 to $1.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.1%. This historical growth can be attributed to the increasing prevalence of glaucoma, a growing aging population, the limitations of conventional glaucoma surgeries, rising awareness of vision preservation, and increasing adoption of cataract surgeries.

The minimally invasive glaucoma surgery (migs) devices market is projected to experience rapid expansion over the upcoming years. This market is forecast to reach a size of $2.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.9%. Factors contributing to this growth during the forecast period include an expanding patient population with glaucoma, increasing adoption of minimally invasive surgical solutions, a surge in demand for outpatient eye procedures, a greater emphasis on patient quality-of-life results, and enhanced availability of specialized ophthalmology centers. Key trends anticipated during the forecast period encompass a growing uptake of minimally invasive glaucoma procedures, an escalating preference for MIGS in cases of early and moderate glaucoma, an increased application of MIGS alongside cataract surgery, the broadening scope of outpatient and ambulatory glaucoma surgeries, and a surging need for glaucoma treatments that are both safer and offer quicker recovery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Which Drivers Are Expected To Impact The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market During The Forecast Period?

The growing occurrence of eye disorders is anticipated to fuel the expansion of minimally invasive glaucoma surgery (MIGS) devices moving forward. Eye disorders comprise a wide array of conditions impacting vision and the eyes, with their prevalence increasing due to shifts in lifestyle, environmental influences, and an aging global population. Minimally invasive glaucoma surgery (MIGS) devices are innovative tools employed in treating various eye diseases, primarily focused on reducing intraocular pressure (IOP) to prevent or control the progression of glaucoma. For instance, in 2024, the National Eye Institute, a US-based government agency, projected that around 2.2 million Americans will be blind or partially blind by 2030. Therefore, the rising incidence of eye disorders acts as a key driver for the minimally invasive glaucoma surgery (MIGS) devices market.

How Is The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Divided Into Segments?

The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –

1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices

2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures

3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space

4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals

Subsegments:

1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents

2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts

3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents

4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices

Which Competitive Trends Are Impacting The Structure Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Leading companies in the minimally invasive glaucoma surgery (MIGS) devices market are prioritizing the development of advanced solutions, such as sustained-release drug-delivery implants, aimed at replacing traditional topical glaucoma treatments. A sustained-release implant is defined as a device that delivers medication continuously over time, thereby improving patient adherence, reducing dosing frequency, and enhancing treatment efficacy. For example, in February 2024, Celanese Corporation, a US-based specialty materials company, collaborated with Glaukos to commercially introduce the iDose® TR (Travoprost Intracameral Implant), leveraging Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This innovation effectively supersedes traditional eye-drop regimens by providing continuous intraocular delivery of travoprost directly to the eye for several months. Integrated within Glaukos’ MIGS portfolio, it offers a minimally invasive therapeutic option that decreases the need for daily eye drops, improves patient compliance, and supports sustained intraocular pressure control, ultimately enhancing long-term treatment outcomes.

Which Major Industry Participants Are Leading The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth?

Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company

Glaucoma Surgery Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Cataract Surgery Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cataract-surgery-devices-and-equipment-global-market-report

Ophthalmic Handheld Surgical Instruments Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-handheld-surgical-instruments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the minimally invasive glaucoma surgery (migs) devices market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market By The End Of 2029?

The minimally invasive glaucoma surgery (migs) devices market has experienced rapid expansion in its size over recent years. It is anticipated to grow from $0.7 billion in 2024 to $0.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 27.6%. The historical surge can be attributed to several factors including enhanced awareness for the prevention of blindness, greater investments in healthcare infrastructure, heightened patient knowledge about advanced corrective vision treatments, a general increase in awareness surrounding advanced corrective vision treatments, and expanded government initiatives.

The minimally invasive glaucoma surgery (migs) devices market is projected to experience substantial expansion in the coming years. This market is forecast to reach $2.29 billion by 2029, achieving a compound annual growth rate (CAGR) of 26.5%. Several factors are contributing to this growth during the projected period, including the rising incidence of eye conditions such as glaucoma, an expanding elderly demographic, improving healthcare infrastructure, and the increasing demand for safer and more effective treatment options. Key trends anticipated for the forecast period encompass the wider adoption of MIGS devices, ongoing technological advancements, the creation of novel minimally invasive glaucoma surgery devices, the evolution of sophisticated implantable devices, and progress in ophthalmic technology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Which Business Drivers Are Underpinning The Growth Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The rising occurrence of ocular conditions is projected to drive the expansion of minimally invasive glaucoma surgery (MIGS) devices in the future. These eye conditions cover a broad spectrum of ailments impacting both vision and the eyes themselves. The growing incidence of eye disorders stems from shifts in lifestyle, environmental factors, and an aging demographic. Minimally invasive glaucoma surgery (MIGS) devices represent advanced instruments employed in treating diverse eye ailments, primarily aiming to lower intraocular pressure (IOP) to impede or manage the advancement of glaucoma. For example, as reported by the National Eye Institute, a US-based government agency, in 2024, approximately 2.2 million Americans are anticipated to experience blindness or partial blindness by 2030. Consequently, the escalating incidence of eye conditions fuels the market for minimally invasive glaucoma surgery (MIGS) devices.

What Are The Principal Segment Types In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The minimally invasive glaucoma surgery (migs) devicesmarket covered in this report is segmented –

1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products

2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma

3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets

4) By Distribution Channel: Direct Tender, Retail Sales

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users

Subsegments:

1) By Valves: Micro Shunt Valves, Non-penetrating Valves

2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants

3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt

4) By Stents: Ab-Interno Stents, Ab-Externo Stents

5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices

How Are Industry Trends Steering The Expansion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Companies at the forefront of the minimally invasive glaucoma surgery (MIGS) devices market are concentrating on developing innovative products, including stent injectable systems, to address unmet needs in glaucoma management and enhance patient outcomes. A stent injectable system functions as a minimally invasive glaucoma surgery (MIGS) device that implants a small stent into the body through an injection-like procedure, frequently employing a specialized delivery mechanism commonly utilized in minimally invasive surgeries for conditions such as blocked or narrowed blood vessels. For instance, in August 2022, Glaukos Corporation, a US-based ophthalmic medical technology company, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent Infinite Trabecular Micro-Bypass System. The iStent Infinite is a novel three-stent injectable system crafted to offer foundational, 24/7 intraocular pressure (IOP) control for patients with primary open-angle glaucoma (POAG) whose IOP has not been controlled by previous medication and surgical therapy.

Which Companies Are Contributing Significantly To The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth?

Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Offers The Most Opportunity For Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Expansion?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2025, By The Business Research Company

Minimally Invasive Surgery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report

Minimally Invasive Surgical Instruments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgical-instruments-global-market-report

Minimally Invasive And Non Invasive Product And Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-and-non-invasive-product-and-service-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market By 2029?

The minimal access surgery market for glaucoma has seen substantial, rapid expansion lately, with projections indicating a rise from a valuation of $0.7 billion in 2024 to $0.89 billion by 2025, reflecting an impressive compound annual growth rate of 27.6%. This upward trajectory observed over the historical period stems from several contributing factors, including heightened recognition regarding avoiding vision loss, greater capital allocation toward health system facilities, growing patient understanding of sophisticated sight correction procedures, rising knowledge about cutting-edge visual correction modalities, and the implementation of supportive governmental programs.

Projections indicate that the market for minimally invasive glaucoma surgery (MIGS) devices is set for substantial, rapid expansion in the coming years, reaching a valuation of $2.29 billion by 2029 with a compound annual growth rate (CAGR) clocked at 26.5%. This upward trajectory through the projection timeframe is largely fueled by several factors, including the escalating incidence of ocular conditions such as glaucoma, an aging global demographic, enhancements in medical infrastructure, and a persistent demand for therapeutic methods that are both safer and yield better outcomes. Key developments shaping this market throughout this phase involve increased integration of MIGS technologies, technological breakthroughs, the creation of novel minimally invasive surgical tools for glaucoma, the engineering of sophisticated implantable apparatuses, and general progress in the field of ophthalmology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

What Are The Main Drivers Boosting The Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry’s Expansion?

The rising incidence of various visual impairments is forecast to act as a catalyst for expanding the market for minimally invasive glaucoma surgery (MIGS) devices in the near future. These eye conditions represent a broad spectrum of ailments impacting ocular health and sight capabilities, their growing frequency being attributable to shifts in daily habits, external surroundings, and the aging demographic trend. MIGS implements represent novel instruments employed in addressing several ophthalmic ailments, chiefly aiming at lowering the pressure inside the eye (IOP) to either halt or manage the advancement of glaucoma; for illustration, projections from the US governmental organization, the National Eye Institute, suggest approximately 2.2 million individuals in the United States will experience some degree of vision impairment by the year 2030, starting from 2024. Consequently, the heightened frequency of eye disorders directly fuels the expansion of the market centered around MIGS apparatus.

What Are The Segment Types Shaping The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The minimally invasive glaucoma surgery (migs) devicesmarket covered in this report is segmented –

1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products

2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma

3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets

4) By Distribution Channel: Direct Tender, Retail Sales

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users

Subsegments:

1) By Valves: Micro Shunt Valves, Non-penetrating Valves

2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants

3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt

4) By Stents: Ab-Interno Stents, Ab-Externo Stents

5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices

What Are The Latest Industry Trends Transforming The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Leading firms within the space for minimally invasive glaucoma surgery (MIGS) devices are concentrating their efforts on creating novel offerings, notably stent injectable systems, aiming to satisfy existing gaps in glaucoma care and enhance results for those affected. A stent injectable system represents a specific type of MIGS apparatus that facilitates the deployment and placement of a tiny stent into the body via a technique resembling an injection, frequently utilizing a purpose-built delivery instrument common in minimally invasive procedures for addressing issues like constricted or obstructed vasculature. As an illustration, in August of 2022, Glaukos Corporation, an American specialist in ophthalmic medical technology, secured 510(k) approval from the United States Food and Drug Administration (FDA) for its iStent Infinite Trabecular Micro-Bypass System. This iStent Infinite is distinguished as a new three-stent injectable mechanism engineered to afford consistent, around-the-clock control over intraocular pressure (IOP) for individuals diagnosed with primary open-angle glaucoma (POAG) whose IOP remains unmanaged despite earlier pharmaceutical interventions and surgical treatments.

Who Are The Prominent Global Companies Shaping The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Is Projected To Lead The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market During The Forecast Period?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2025, By The Business Research Company

Minimally Invasive Surgery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report

Minimally Invasive Surgical Instruments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgical-instruments-global-market-report

Minimally Invasive And Non Invasive Product And Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/minimally-invasive-and-non-invasive-product-and-service-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model